Cutler Group LP Bio Xcel Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 3,000 shares of BTAI stock, worth $5,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,000

Previous 3,100 3.23%

Holding current value

$5,430

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$1.95 - $4.04 $195 - $404	-100 Reduced 3.23%	3,000 $8,000
Q4 2023 Jan 18, 2024	SELL	$2.32 - $5.51 $7,191 - $17,081	-3,100 Reduced 50.0%	3,100 $9,000
Q3 2023 Nov 07, 2023	SELL	$2.49 - $11.85 $1,805 - $8,591	-725 Reduced 10.47%	6,200 $15,000
Q2 2023 Jul 18, 2023	BUY	$6.39 - $28.58 $44,250 - $197,916	6,925 New	6,925 $46,000
Q4 2022 Feb 07, 2023	SELL	$10.25 - $22.43 $20,500 - $44,860	-2,000 Reduced 69.76%	867 $18,000

Q3 2022 Oct 25, 2022	SELL	$11.19 - $17.89 $12,309 - $19,679	-1,100 Reduced 27.73%	2,867 $33,000
Q2 2022 Aug 04, 2022	BUY	$9.03 - $21.55 $22,277 - $53,163	2,467 Added 164.47%	3,967 $52,000
Q1 2022 Apr 14, 2022	SELL	$15.0 - $22.83 $12,000 - $18,264	-800 Reduced 34.78%	1,500 $31,000
Q4 2021 Jan 18, 2022	SELL	$20.12 - $35.09 $12,072 - $21,054	-600 Reduced 20.69%	2,300 $46,000
Q3 2021 Oct 26, 2021	SELL	$23.84 - $32.03 $2,384 - $3,203	-100 Reduced 3.33%	2,900 $88,000
Q2 2021 Jul 19, 2021	SELL	$29.06 - $38.83 $6,974 - $9,319	-240 Reduced 7.41%	3,000 $87,000
Q1 2021 Apr 26, 2021	SELL	$39.04 - $64.6 $146,790 - $242,895	-3,760 Reduced 53.71%	3,240 $139,000
Q4 2020 Jan 21, 2021	BUY	$42.46 - $56.58 $125,341 - $167,024	2,952 Added 72.92%	7,000 $323,000
Q3 2020 Oct 27, 2020	SELL	$37.44 - $64.63 $215,579 - $372,139	-5,758 Reduced 58.72%	4,048 $175,000
Q2 2020 Jul 22, 2020	BUY	$17.62 - $58.71 $91,342 - $304,352	5,184 Added 112.16%	9,806 $519,000
Q1 2020 May 07, 2020	BUY	$12.26 - $41.14 $56,665 - $190,149	4,622 New	4,622 $103,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

6.6M

Call Options Held

85K

Put Options Held

221K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $50.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account